Ben Aylesworth.
Acentra Health strategy · November 2026

I’d rank Acentra’s investment bets by when each one returns cash.

I’d fund clinical review first, because it bills monthly while systems builds pay back over years.

Carlyle-owned since 2021;1 bought FEI Systems in Aug 2026.2

Systems builds score best on returns but wait 18 to 36 months for first cash.

Months from first spend to first cash, all my estimates.3

Line of businessEBITDA1 to 3ROI1 to 3
  1. Clinical review and assessmentsUtilization management, PASRR screeningFund first
    EBITDA
    ROI
    Fastest cash, high ROI Estimate: about 1 to 3 months

    Sourced: Renewals in Colorado, five years (Aug 2026), and California, $27.5M over two years (2025).4

  2. Medicaid systemsClaims and enterprise systems for statesFund in stages to go‑live
    EBITDA
    ROI
    Likely slowest, best returns Estimate: about 18 to 36 months

    Sourced: Idaho’s claims system pays out over $300M a month.5

  3. Federal quality reviewMedicare quality improvement work for CMSProtect the margin
    EBITDA
    ROI
    Same timing, lower ROI Estimate: about 1 to 3 months

    Sourced: $298M CMS renewal, 29 states, to Apr 2029.6

  4. Long-term care and behavioral healthHome and community care technology, from FEIFund integration milestones
    EBITDA
    ROI
    Likely thinnest margin Estimate: about 6 to 18 months

    Sourced: FEI adds 500+ people.2 Estimate: margins least known.

This is a starting order, and Acentra’s own numbers by line would reset it in the first quarterly sprint.

How I’ve tackled a fixed investment budget

I ran product for a $30M AI startup inside Bayer and owned its P&L. Through quarterly planning sprints I directed $30M a year, ranking bets on EBITDA, cash flow and ROI and moving money and people from underperforming projects to stronger ones. Acentra’s four lines compete for dollars the same way.

The three pressures I’d check first all reach cash before they reach EBITDA.

  1. State clients have less to spend at rebid. Nearly two-thirds of states rated a 2026 Medicaid shortfall 50-50 or likelier (Nov 2025).7 To check: State versus federal revenue, and 2027 rebids.
  2. Work requirements could add review work. States must start them by Jan 1, 2027 (CMS rule, Jun 2026).8 To check: Which vendors states buy the checks from.
  3. Systems contracts spend cash before go‑live. Idaho’s claims move to Acentra awaits a court ruling (Apr 2026).5 To check: Spend before go‑live, and FEI integration targets.2

Each funded bet would reach the executive team with the outcome it moves and the cash it returns.

At Aidoc I built ROI models for COO and CFO buyers into business cases and renewals, and the foundation-model launch reached an eight-figure pipeline in year one. Each Acentra case would carry three things.

  1. The outcome a state or CMS client sees
  2. EBITDA and cash by quarter
  3. The result that stops the funding, agreed up front

I’d test the order with two quarters of cash conversion on funded bets, against held‑back bets and the same quarters a year earlier.

Cash moves within a quarter; EBITDA follows a renewal later. Like quarters keep state fiscal-year timing out of the read. If held‑back bets improve as much, the market did it.

ben.aylesworth@gmail.com